Results 201 to 210 of about 132,650 (237)
Some of the next articles are maybe not open access.
Reactions Weekly, 2017
Guidelines generally recommend proton pump inhibitors (PPIs) over histamine type 2 receptor antagonists when acid suppression is advocated because of a longer duration of action, a superior ability in reducing acid secretion, and the absence of tachyphylaxis with repeated dosing.
Licia Pensabene, Geoffrey Davidson
openaire +2 more sources
Guidelines generally recommend proton pump inhibitors (PPIs) over histamine type 2 receptor antagonists when acid suppression is advocated because of a longer duration of action, a superior ability in reducing acid secretion, and the absence of tachyphylaxis with repeated dosing.
Licia Pensabene, Geoffrey Davidson
openaire +2 more sources
Deprescribing Proton Pump Inhibitors
JAMA Internal Medicine, 2020Jacob E, Kurlander +2 more
openaire +4 more sources
â–¼Lansoprazole - another proton pump inhibitor
Drug and Therapeutics Bulletin, 1995Lansoprazole (Zoton - Lederle) is a proton pump inhibitor recently licensed for the treatment of duodenal ulcer, benign gastric ulcer or reflux oesophagitis. It is structurally related to omeprazole, which has now been available in the UK for 6 years. In this article we consider the place of lansoprazole in the treatment of patients with acid-related ...
openaire +2 more sources